Autoplaque vs TOMTEC-ARENA
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is highly specialized, AI-driven quantitative analysis of coronary plaques and and luminal stenoses specifically from CT angiography images. This tool is ideal for cardiologists and radiologists focused on precise heart attack risk prediction and guiding treatment strategies based on detailed coronary artery pathology.
View Autoplaque →Choose TOMTEC-ARENA if…
Choose TOMTEC-ARENA if you require a versatile, multimodality, and vendor-neutral platform for advanced medical image analysis, quantification, and structured reporting across various specialties. This solution is best suited for institutions or practices seeking flexible deployment options, including web-based workflows, to integrate comprehensive image analysis and data management into their existing PACS/EMR systems.
View TOMTEC-ARENA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | TOMTEC-ARENA |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | On-premise |
| FDA Status | Cleared AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TOMTEC-ARENATOMTEC-ARENA offers web-based diagnostic workflows and multimodality support, which generally provides greater flexibility and accessibility for users across various platforms and locations. While Autoplaque features clinician-reviewable and editable segmentation, TOMTEC-ARENA's broader deployment options and modern workflow approach suggest a more adaptable user experience.
Clinical Value
AutoplaqueAutoplaque provides highly specialized and critical clinical value by directly aiding in heart attack risk prediction through precise quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. While TOMTEC-ARENA offers broad utility across multiple modalities and specialties, Autoplaque's focused application addresses a specific, high-stakes clinical problem with direct patient impact.
Pricing & Value
TOMTEC-ARENATOMTEC-ARENA provides significantly more transparency regarding its licensing and support models, including concurrent user licenses, tailored options for different organizational sizes, and maintenance contracts. Autoplaque offers no disclosed pricing information, making it impossible to assess its cost structure or overall value proposition.
Enterprise Readiness
TOMTEC-ARENATOMTEC-ARENA demonstrates superior enterprise readiness with its flexible deployment options, including on-premise, cloud-hybrid, and client-server networks, alongside explicit mention of DICOM connectivity, PACS/EMR integration, and automated archiving. Autoplaque's workstation-only deployment is less scalable and integrated for large enterprise environments.
Innovation
AutoplaqueAutoplaque's innovation lies in its highly specialized and precise AI application for quantitative analysis of coronary plaques and luminal stenoses, directly addressing a complex and critical challenge in heart attack risk prediction. While TOMTEC-ARENA offers innovative platform features like multimodality and web-based workflows, Autoplaque's deep dive into a specific, high-impact diagnostic area represents a more focused and potentially groundbreaking AI application.
Support & Docs
TOMTEC-ARENATOMTEC-ARENA explicitly mentions offering a 'premium TOMTEC service with an Up-to-Date maintenance contract,' indicating a structured and comprehensive approach to customer support. Autoplaque provides no details regarding its support offerings or documentation, making it impossible to evaluate this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | TOMTEC-ARENA |
|---|---|---|
| Name | Autoplaque | TOMTEC-ARENA |
| Company | Cedars-Sinai Medical Center: AIM | TOMTEC Imaging Systems GmbH |
| Tagline | AI-Powered Quantitative Analysis for Coronary Plaque and Stenosis | Excellence in Digital Healthcare |
| Description | Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | TOMTEC-ARENA is an AI-powered, multimodality, vendor-neutral software for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology, with web-based workflows. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Radiology | Cardiology, Radiology |
| Key Features (partial) | AI-powered quantitative analysis of atherosclerotic plaque, Detection and characterization of coronary artery plaque, Measurement of luminal stenoses | AI-based measurement automation and data analytics, Multimodality and vendor-neutral imaging and analysis, Web-based diagnostic workflows (TOMTEC ZERO) |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and TOMTEC-ARENA.